The global Car T Cell Therapy Market is estimated to be valued at US$ 12709.23 Mn in 2023 and is expected to exhibit a CAGR of 20.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Car T cell therapy uses genetically modified T cells, a type of white blood cell, known as chimeric antigen receptor (CAR) T cells that are designed to recognize and attack cancer cells ... Read more
